Zobrazeno 1 - 10
of 43
pro vyhledávání: '"M E, Osband"'
Autor:
H.N. Weber, J. E. Gold, Pamela D. Unger, I. Leventhal, T.R. Masters, Eugene M. Fine, C.D. Zippe, M. E. Osband, B. Babbit
Publikováno v:
British Journal of Urology. 76:115-122
Objective To determine if cis-diamminedichloroplat-inum(II) (CDDP) enhances, by immune-modulation, ex vivo anti-tumour cytotoxicity of autolymphocyte therapy (ALT) against a chemotherapy-resistant tumour, and if lysis is mediated through T-cells, NK-
Publikováno v:
The Journal of surgical research. 59(2)
Autolymphocyte therapy (ALT) is adoptive cellular therapy of neoplastic disease based upon ex vivo activation of lymphocytes by either the supernatant derived from a previously prepared one-way mixed lymphocyte culture (MLC) or using low doses of the
Autor:
S, Graham, R K, Babayan, D L, Lamm, I, Sawczuk, S D, Ross, P T, Lavin, M E, Osband, R J, Krane
Publikováno v:
Seminars in urology. 11(1)
Publikováno v:
Transplantation proceedings. 24(6)
Publikováno v:
Transplantation proceedings. 24(6)
Publikováno v:
Urology. 35(5)
Thirty-six patients with Stage IV renal cell carcinoma were treated with autolymphocyte therapy (ALT). This new form of adoptive immunotherapy is based on the infusion of relatively small numbers of autologous lymphocytes that are depleted of suppres
Autor:
M E, Osband, G W, Cashon
Publikováno v:
Clinical research. 38(1)
Publikováno v:
Natural immunity and cell growth regulation. 9(3)
Several viruses have been evaluated as potential agents for cancer treatment using either their oncolytic properties, in order to lyse cancer cells, or their potential augmenting effects on the immune response to tumors. However, the direct oncolytic
Publikováno v:
Journal of Pediatric Hematology/Oncology. 21:336
Publikováno v:
Journal of Pediatric Hematology/Oncology. 21:336